Rett syndrome: "We'll keep the genes on for you"

Neurology

Volumn 56, Issue 5, 2001, Pages 582-585

  Singer, Harvey S ^a,b   Naidu, SakkuBai ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMIDINE NUCLEOTIDE;

AUTISM; CPG ISLAND; EDITORIAL; GENE MAPPING; GENE MUTATION; GENOTYPE; HUMAN; MENTAL DEFICIENCY; PHENOTYPE; PRIORITY JOURNAL; RETT SYNDROME; X CHROMOSOME DOMINANT INHERITANCE;

EID: 0035853018     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.56.5.582     Document Type: Editorial

References (38)

1. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases
2. Diagnostic criteria for Rett syndrome
3. Rett variants: A suggested model for inclusion criteria
4. Examination of X chromosome markers in Rett syndrome: Exclusion mapping with a novel variation on multilocus linkage analysis
5. Rett syndrome: Confirmation of x-linked dominant inheritance, and localization of the gene to Xq28
6. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
7. Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots
8. Clinical criteria, stages and natural history
9. Rett syndrome: Critical examination of clinical features, serial EEG and video-monitoring in understanding and management
10. Rett syndrome, EEG and the motor cortex as a model for better understanding of attention deficit hyperactivity disorder (ADHD)
11. Rett syndrome: Clinical peculiarities, diagnostic approach and possible cause
12. Rett variants-Rettoid phenotypes
13. "Forme fruste" of Rett syndrome - A case report
14. The Rett girls with preserved speech
15. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males
16. Male Rett syndrome variant: Application of diagnostic criteria
17. Histone deacetylase directs the dominant silencing of transcription in chromatin: Association with MeCP2 and the Mi-2 chromodomain SWI/SNF ATPase
18. Histone deacetylases associated with the mSin3 corepressot mediate mad transcriptional repression
19. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2
20. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA
21. Rett syndrome: A surprising result of mutation in MECP2
22. MeCP2 mutations in children with and without the phenotype of Rett syndrome
23. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
24. The spectrum and parental origin of de novo mutations of methyl-CpG-binding protein 2 gene (MECP2) in Rett syndrome
25. Mutation screening in Rett syndrome patients
26. MECP2 mutations account for most cases of typical forms of Rett syndrome
27. Rett syndrome: Analysis of MECP2 and clinical characterization of 31 patients
28. MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features
29. MECP2 mutation in male patients with non-specific X-linked mental retardation
30. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males
31. Rett syndrome: XH spectroscopic imaging at 4.1 Tesla
32. 1H MR spectroscopic imaging in early Rett syndrome
33. Altered cholinergic functionin the basal forebrain of girls with Rett syndrome
34. Altered-neurochemical markers in Rett's syndrome
35. Decreased cerebrospihal fluid levels of beta-phenylethylamine in patients with Rett syndrome
36. Development of amino acid receptors in frontal cortex from girls with Rett syndrome
37. Studies on mitochondrial pathogenesis of Rett syndrome: Ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835